(19)
(11) EP 3 197 476 A1

(12)

(43) Date of publication:
02.08.2017 Bulletin 2017/31

(21) Application number: 15770619.3

(22) Date of filing: 21.09.2015
(51) International Patent Classification (IPC): 
A61K 38/12(2006.01)
A61K 31/4196(2006.01)
A61K 31/7048(2006.01)
A61K 31/145(2006.01)
A61K 31/497(2006.01)
A61P 31/10(2006.01)
(86) International application number:
PCT/GB2015/052714
(87) International publication number:
WO 2016/046524 (31.03.2016 Gazette 2016/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 22.09.2014 GB 201416727
22.09.2014 US 201462053523 P

(71) Applicant: Novabiotics Limited
Craibstone Aberdeen AB21 9TR (GB)

(72) Inventors:
  • O'NEIL, Deborah
    Aberdeen Aberdeenshire AB21 9TR (GB)
  • DUNCAN, Vanessa
    Aberdeen Aberdeenshire AB21 9TR (GB)

(74) Representative: Harrison IP Ltd. 
3 Ebor House London Ebor Business Park Millfield Lane
Nether Poppleton York YO26 6QY
Nether Poppleton York YO26 6QY (GB)

   


(54) USE OF CYSTEAMINE IN TREATING INFECTIONS CAUSED BY YEASTS/MOULDS